Your browser doesn't support javascript.
loading
PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Mittlmeier, L M; Unterrainer, M; Todica, A; Cyran, C C; Rodler, S; Bartenstein, P; Stief, C G; Ilhan, H; Staehler, M.
Afiliación
  • Mittlmeier LM; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  • Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Todica A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Cyran CC; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Rodler S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Bartenstein P; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
  • Stief CG; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
  • Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Staehler M; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Eur J Nucl Med Mol Imaging ; 47(9): 2216-2217, 2020 08.
Article en En | MEDLINE | ID: mdl-31925458

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma de Células Renales / Neoplasias Renales Límite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Carcinoma de Células Renales / Neoplasias Renales Límite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2020 Tipo del documento: Article País de afiliación: Alemania